Home - Products - Others - Other Targets - 2-Butenoic acid, 2-methyl-, (3aS,4R,6E,10R,11aR)-2,3,3a,4,5,8,9, 10,11,11a-decahydro-6,10-bis(hydroxymethyl)-3-methylene-2-ox ocyc lodeca[b]furan-4-yl ester,(2Z)-

2-Butenoic acid, 2-methyl-, (3aS,4R,6E,10R,11aR)-2,3,3a,4,5,8,9, 10,11,11a-decahydro-6,10-bis(hydroxymethyl)-3-methylene-2-ox ocyc lodeca[b]furan-4-yl ester,(2Z)-

CAS No. 849693-09-0

2-Butenoic acid, 2-methyl-, (3aS,4R,6E,10R,11aR)-2,3,3a,4,5,8,9, 10,11,11a-decahydro-6,10-bis(hydroxymethyl)-3-methylene-2-ox ocyc lodeca[b]furan-4-yl ester,(2Z)-( ——— )

Catalog No. M38389 CAS No. 849693-09-0

Anti-osteoporosis agent-2 (Compound 10) is an anti-osteoporosis agent. Anti-osteoporosis agent-2 inhibits differentiation on osteoclast induced by RANKL.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    2-Butenoic acid, 2-methyl-, (3aS,4R,6E,10R,11aR)-2,3,3a,4,5,8,9, 10,11,11a-decahydro-6,10-bis(hydroxymethyl)-3-methylene-2-ox ocyc lodeca[b]furan-4-yl ester,(2Z)-
  • Note
    Research use only, not for human use.
  • Brief Description
    Anti-osteoporosis agent-2 (Compound 10) is an anti-osteoporosis agent. Anti-osteoporosis agent-2 inhibits differentiation on osteoclast induced by RANKL.
  • Description
    Anti-osteoporosis agent-2 (Compound 10) is an anti-osteoporosis agent. Anti-osteoporosis agent-2 inhibits differentiation on osteoclast induced by RANKL.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    849693-09-0
  • Formula Weight
    364.43
  • Molecular Formula
    C20H28O6
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Qiong Gu, et al. Gilmane type sesquiterpene lactone compound and preparation method and application thereof. Patent CN112159378A.
molnova catalog
related products
  • Neuropeptide Y (29-6...

    Neuropeptide Y (29-64), amide, human (TFA) is involved in Alzheimer's disease (AD) and protects rat cortical neurons against β-Amyloid toxicity.It is showed that Neuropeptide Y (29-64), amide, human (TFA) is able to protect cortical neurons from Aβ25-35 toxicity.

  • Ciamexon

    Ciamexon (Ciamexone) is a novel immunomodulator that has shown promising results in experimental models of autoimmune disease with little demonstrated cytotoxicity.

  • VT104

    VT104 is a potent and orally active YAP/TAZ inhibitor for cancer research. VT104 blocks palmitoylation of endogenous TEAD1 and TEAD3 proteins.